Physicists and clinicians for the TJU Radiation Oncology Department joined the ELEKTA Research Consortium early in 1998. The consortium consists of a number of prestigious institutions from around the world. Consortium meetings take place in England twice each year. The main purpose of the consortium is to help ELEKTA make Intensity Modulated Radiation Therapy (IMRT) available to their customers. In this advisory role, the consortium members have made significant contributions to the understanding of this new treatment modality. The consortium members are listed below.

William Beaumont Hospital, Detroit, MI

• Dr. John Wong Dr. Peter Chen
• Dr. Donald Brabbins Dr. Michael Sharpe
• Dr. Frank A. Vicni

University of Maryland, Baltimore, MD

• Dr. Cedric Yu Dr. Carl Mansfield

University of Washington, Seattle, WA

• Dr. Mark Phillips

University of Gent, Belgium

• Prof. Wilfred De Neve
• Dr. Luc Vakaet
• Prof. Carlos de Wagter
• Dr. Bart Van Duyse

Royal Marsden Hospital, London, UK

• Prof. Steve Webb
• Dr. Vivian Cosgrove
• Dr. Dave Convery
• Dr. Mike Partridge
• Dr. Phil Evans
• Dr. Chris Nutting

The Netherlands Cancer Institute, Amsterdam

• Dr. Ben Mijnheer
• Dr. Roel. de Boer

The Christie Hospital, Manchester, UK

• Dr. Peter Williams
• Ms. Judith Mott
• Dr. Geoff Budgell
• Mr. Alan Hounsell
• Mr. John Wilkinson
• Dr. John Logue

Thomas Jefferson University, Philadelphia, PA

• Dr. James Galvin
• Dr. Richard Valicenti
• Dr. Ying Xiao

Elekta Oncology Systems

• EOS, North America
  Rajinder Dhada
  
  
• EOS, Crawley, UK
  

Neil Harvey
Gerry Van Oortmarssen
Andy Niven
Peter Hart
Kevin Brown
Steve Gwynne
Volker Stieber Neil Dodd

Medical Physics Home